SCHEMBL19309922

SCHEMBL19309922

BC1(B)c2c(N)cc(F)cc2C(=O)N1[C@]1(O)C(=O)NC(=O)CC1(B)B

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ AKR1B1 P15121 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21927072 0.86 AKR1B1 (0.32) AKR1B1
SCHEMBL22199340 0.81 — —
SCHEMBL21925221 0.81 — —
SCHEMBL22199360 0.80 AKR1B1 (0.34) AKR1B1
SCHEMBL19310186 0.78 AKR1B1 (0.33) AKR1B1
SCHEMBL21281328 0.76 CYP19A1 (0.35) —
SCHEMBL19310041 0.71 — —
SCHEMBL23470170 0.71 DDB1 (0.33) —
SCHEMBL23470212 0.70 — —
SCHEMBL19309913 0.68 AKR1B1 (0.32) AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3214081-A1 ISOINDOLINE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF Kangpu Biopharmaceuticals, Ltd. (CN) 2017-09-06 — — EP disclosed
Send feedback